Older patients benefit from obesity surgery too

	Tweet

Stomach bypass surgery, using “keyhole,” or laparoscopic techniques, is a safe method of achieving weight loss in older patients and the benefits in this age group are similar to those seen in younger patients, new research shows.

The results suggest that “patients older than 60 years can be considered good candidates for obesity surgery,” senior author Dr. James M. Swain and colleagues, from the Mayo Clinic Scottsdale in Arizona, note.

However, longer patient follow-up is needed to determine whether the postoperative benefits “translate into a long-term survival benefit or overall health cost savings.”

The findings, which appear in Archives of Surgery, are based on a comparison of 110 patients younger than 60 years and 20 patients older than 60 years who underwent laparoscopic stomach surgery at the authors’ institution.

The complication rate and the hospital length of stay was no different for younger and older patients, the investigators note.

Younger patients experienced greater weight loss than and more complete resolution of weight-related diseases than older patients. However, older patients showed a greater overall reduction in medication needs.

“Patients of advanced age can safely undergo (stomach bypass surgery) with operative results nearly identical to those of younger patients,” the team concludes.

SOURCE: Archives of Surgery, February 2005.

RELATED STORIES:
Weight in pregnancy best controlled by diet, study shows   FDA advisers recommend approving weight loss drug   Bridal Hunger Games   Exercise, Group Support Work for Weight Loss   Misperception of weight is an important barrier to weight loss   Obesity drugs need heart studies, U.S. advisers say   Weight Loss Surgery and Diabetes: Expert Interview Opportunity   New evidence on effects of green coffee beans in weight loss   Chocolate lovers tend to weigh less: study   Weight loss won’t necessarily help teen girls’ self-esteem   How to Best Help Your Child Lose Weight: Lose Weight Yourself   Qnexa: Is the new anti-obesity drug too risky?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]